Moreover, RT-qPCR and Western Blot assays showed that the expression levels of OCT4 and ALDH1A1 in RCC cells treated with CAF-181sponge-Exo were obviously decreased compared with that treated with CAF-Exo (Fig. 6E, F). The gene discussed is ALDH1A1; the disease is renal cell carcinoma.